200 related articles for article (PubMed ID: 38402619)
21. The yin and the yang of follicular lymphoma cell niches: role of microenvironment heterogeneity and plasticity.
Amé-Thomas P; Tarte K
Semin Cancer Biol; 2014 Feb; 24():23-32. PubMed ID: 23978491
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
23. Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.
Wang J; Press OW; Lindgren CG; Greenberg P; Riddell S; Qian X; Laugen C; Raubitschek A; Forman SJ; Jensen MC
Mol Ther; 2004 Apr; 9(4):577-86. PubMed ID: 15093188
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of a novel 'double-hit' follicular lymphoma cell line, FL-SJC.
Chen M; Jiang G; Liu Y; Li D; Li T; Peng J; Jiang Q; You H; Ba R; Pan J; Li M; Long W; Yan J; Zhu Y; Wang Y; Xi X; Mao J; Shi X
J Cell Mol Med; 2020 Jul; 24(14):7928-7938. PubMed ID: 32459397
[TBL] [Abstract][Full Text] [Related]
25. Revealing the evolution of the tumor immune microenvironment in follicular lymphoma patients progressing within 24 months using single-cell imaging mass cytometry.
Liu L; Yu X; Li Z; He X; Zha J; Lin Z; Hong Y; Zheng H; Lai Q; Ding K; Jia X; Fu G; Yu H; Yang H; Li Z; Young KH; Xu B
J Hematol Oncol; 2022 Aug; 15(1):115. PubMed ID: 35996180
[TBL] [Abstract][Full Text] [Related]
26. Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cells.
Amé-Thomas P; Le Priol J; Yssel H; Caron G; Pangault C; Jean R; Martin N; Marafioti T; Gaulard P; Lamy T; Fest T; Semana G; Tarte K
Leukemia; 2012 May; 26(5):1053-63. PubMed ID: 22015774
[TBL] [Abstract][Full Text] [Related]
27. TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.
Kotsiou E; Okosun J; Besley C; Iqbal S; Matthews J; Fitzgibbon J; Gribben JG; Davies JK
Blood; 2016 Jul; 128(1):72-81. PubMed ID: 27103745
[TBL] [Abstract][Full Text] [Related]
28. The follicular lymphoma tumor microenvironment at single-cell and spatial resolution.
Radtke AJ; Roschewski M
Blood; 2024 Mar; 143(12):1069-1079. PubMed ID: 38194685
[TBL] [Abstract][Full Text] [Related]
29. Grade I, II and III Follicular Lymphomas Express Ig V
Csernus B; Timár B; Fülöp Z; Matolcsy A
Pathol Oncol Res; 2020 Oct; 26(4):2765-2772. PubMed ID: 32705429
[TBL] [Abstract][Full Text] [Related]
30. Follicular lymphoma dynamics.
Milpied P; Gandhi AK; Cartron G; Pasqualucci L; Tarte K; Nadel B; Roulland S
Adv Immunol; 2021; 150():43-103. PubMed ID: 34176559
[TBL] [Abstract][Full Text] [Related]
31. Unveiling the Role of the Tumor Microenvironment in the Treatment of Follicular Lymphoma.
Blanco M; Collazo-Lorduy A; Yanguas-Casás N; Calvo V; Provencio M
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565286
[TBL] [Abstract][Full Text] [Related]
32. Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
Haebe S; Shree T; Sathe A; Day G; Czerwinski DK; Grimes SM; Lee H; Binkley MS; Long SR; Martin B; Ji HP; Levy R
Blood; 2021 May; 137(21):2869-2880. PubMed ID: 33728464
[TBL] [Abstract][Full Text] [Related]
33. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stromal cells support the viability and differentiation of follicular lymphoma-infiltrating follicular helper T-cells.
Brady MT; Hilchey SP; Hyrien O; Spence SA; Bernstein SH
PLoS One; 2014; 9(5):e97597. PubMed ID: 24836297
[TBL] [Abstract][Full Text] [Related]
35. High TNFRSF14 and low BTLA are associated with poor prognosis in Follicular Lymphoma and in Diffuse Large B-cell Lymphoma transformation.
Carreras J; Lopez-Guillermo A; Kikuti YY; Itoh J; Masashi M; Ikoma H; Tomita S; Hiraiwa S; Hamoudi R; Rosenwald A; Leich E; Martinez A; Roncador G; Villamor N; Colomo L; Perez P; Tsuji NM; Campo E; Nakamura N
J Clin Exp Hematop; 2019; 59(1):1-16. PubMed ID: 30918139
[TBL] [Abstract][Full Text] [Related]
36. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
Radtke AJ; Postovalova E; Varlamova A; Bagaev A; Sorokina M; Kudryashova O; Meerson M; Polyakova M; Galkin I; Svekolkin V; Isaev S; Wiebe D; Sharun A; Sarachakov A; Perelman G; Lozinsky Y; Yaniv Z; Lowekamp BC; Speranza E; Yao L; Pittaluga S; Shaffer AL; Jonigk D; Phelan JD; Davies-Hill T; Huang DW; Ovcharov P; Nomie K; Nuzhdina E; Kotlov N; Ataullakhanov R; Fowler N; Kelly M; Muppidi J; Davis JL; Hernandez JM; Wilson WH; Jaffe ES; Staudt LM; Roschewski M; Germain RN
Cancer Cell; 2024 Mar; 42(3):444-463.e10. PubMed ID: 38428410
[TBL] [Abstract][Full Text] [Related]
37. Antitransgene rejection responses contribute to attenuated persistence of adoptively transferred CD20/CD19-specific chimeric antigen receptor redirected T cells in humans.
Jensen MC; Popplewell L; Cooper LJ; DiGiusto D; Kalos M; Ostberg JR; Forman SJ
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1245-56. PubMed ID: 20304086
[TBL] [Abstract][Full Text] [Related]
38. Locoregional treatment of low-grade B-cell lymphoma with CD3xCD19 bispecific antibodies and CD28 costimulation. II. Assessment of cellular immune responses.
Manzke O; Tesch H; Lorenzen J; Diehl V; Bohlen H
Int J Cancer; 2001 Feb; 91(4):516-22. PubMed ID: 11251975
[TBL] [Abstract][Full Text] [Related]
39. Cross talk between follicular Th cells and tumor cells in human follicular lymphoma promotes immune evasion in the tumor microenvironment.
Rawal S; Chu F; Zhang M; Park HJ; Nattamai D; Kannan S; Sharma R; Delgado D; Chou T; Lin HY; Baladandayuthapani V; Luong A; Vega F; Fowler N; Dong C; Davis RE; Neelapu SS
J Immunol; 2013 Jun; 190(12):6681-93. PubMed ID: 23686488
[TBL] [Abstract][Full Text] [Related]
40. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma.
Matarasso S; Assouline S
Future Oncol; 2023 Oct; 19(31):2083-2101. PubMed ID: 37882361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
